Health

Dr. Kizzmekia S. Corbett is an immunologist and assistant professor of immunology and infectious diseases at Harvard Chan School. Corbett focuses on developing vaccines that will fight viruses such as COVID-19.

Corbett and her team of experts designed a vaccine with mRNA-1273 and later partnered with Moderna.

Only 66 days after the viral sequence release, the Moderna vaccine passed the phase 1 clinical trial.

After many tests and positive results in animal models and humans, the Moderna vaccine was approved after the phase 3 clinical trial, which made it safe for it to be distributed and used.

According to the Centers for Disease Control and Prevention, “Moderna’s (vaccine) elicits a stronger immune response and might be better at preventing breakthrough infections.”

Corbett’s work resulted in her receiving the TIME Magazine Hero of the Year designation. Now Corbett fights against any misinformation about vaccines that might create confusion while developing new ways to enhance the medical field.